genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
T-cell lymphoma
Cancer
Novel Technique Makes Cancer’s Power Turn Against Itself
Genome Editing
AAV Vectors Advance the Frontiers of Gene Therapy
Drug Discovery
Exploring Biology Through a New Lens: A Spatial Approach
Cancer
Innate Immunity: French Biotech Builds Antibody Pipeline against Cancer
Cancer
EC Approves Actelion’s Topical Chlormethine Gel for MF-Type CTCL
Drug Discovery
Affimed and MD Anderson Combine NK Cells and Bispecific Abs for Cancer Therapy
Industry News
Mallinckrodt to Acquire Therakos for $1.325B
Cancer
BioAlliance Pharma Buying Topotarget, Adding Potential Blockbuster to Pipeline
Cancer
Valeant Buys Targretin’s U.S. Rights from Eisai for $65M+
Cancer
Yaupon Raises $14.4M to Commercialize Topical Cutaneous T-Cell Lymphoma Drug
1
2
Page 1 of 2
Scroll Up